ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Medical Genetics, PhD Medical Genetics

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,910Medicare Part D Prescriptions Filled, Including Refills
$391K Total Retail Price of All Prescriptions
487 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 419 354
AMLODIPINE BESYLATE 323 295
OMEPRAZOLE 245 201
LOSARTAN-HYDROCHLOROTHIAZIDE 230 191
LEVOTHYROXINE SODIUM 214 201
FLUTICASONE PROPIONATE 199 180
CARVEDILOL 165 141
CRESTOR 160 145
NEXIUM 145 125
DIOVAN HCT 141 136
METOPROLOL SUCCINATE 140 129
METFORMIN HCL 127 104
ALENDRONATE SODIUM 124 115
HYDROCHLOROTHIAZIDE 117 103
METOPROLOL TARTRATE 114 89
FENOFIBRATE 110 87
MELOXICAM 102 86
LOSARTAN POTASSIUM 100 78
LISINOPRIL 95 93
GLYBURIDE-METFORMIN HCL 94 76 R
GLYBURIDE 93 89 R
DIOVAN 87 84
SERTRALINE HCL 85 80
CLONIDINE HCL 85 65
GLIMEPIRIDE 67 67
ZOLPIDEM TARTRATE 65 58
DICLOFENAC SODIUM 65 59
LOVAZA 64 53
AZITHROMYCIN 63 53
DONEPEZIL HCL 61 60
ACTOS 61 61
LANTUS 54 32
ATENOLOL 51 43
ADVAIR DISKUS 50 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.